ARCHIVES

Conversation with Walter Curran – Proton Therapy: What’s Known and What’s Not

This article is from The Cancer Letter archive.

Vol. 39 No. 40 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

Cancer Groups Propose Six Characteristics Of Next FDA Head.

December 19, 2008

FDA Oncologic Drugs Advisory Committee: Trials In A Small Indication Tell Big Story About Pitfalls of Delaying Progression

April 15, 2011

Patient Advocacy: Prostate Cancer coalition Is Formed

September 6, 1996

NCAB Delays Approval Of New Comprehensive Center Guidelines

October 12, 1979

In Brief: Top Priority: Keep Rauscher; Pay Raise Bill No Moving; Miller, Holland Head AACR, ASCO

May 21, 1976

The Selling Begins: CT Offered Beyond High-Risk Group

November 26, 2010